Sanjay Shukla, CEO of aTYR Pharma ATYR, has filed 6 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $3,670. The latest trade was on 02/04.

SS

SS

Sanjay Shukla

President and CEO

Company

aTYR Pharma ATYR

First filing

23/02/06

Trades

19 trades

Buys / sales

6 / 1

12-month net buying

−$3,670

Last trade

02/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
aTYR PharmaATYR	Open-market sale	02/04	02/04	3,745 sh	$0.98	$3,670.1	−2.4%
aTYR PharmaATYR	Open-market buy	24/05/31	24/06/03	20,000 sh	$1.81	$36,200	+17.2%
aTYR PharmaATYR	Open-market buy	23/12/11–23/12/12	23/12/12	15,000 sh2 trades	$1.18avg.	$17,670	+16.5%
aTYR PharmaATYR	Open-market buy	23/11/10–23/11/13	23/11/13	15,000 sh2 trades	$1.11avg.	$16,692.66	+19.7%
aTYR PharmaATYR	Open-market buy	23/07/28	23/08/01	15,000 sh	$2.01	$30,150	+24.5%